Ovarian hormone loss induces bioenergetic deficits and mitochondrial β-amyloid

Neurobiology of Aging

Volumn 33, Issue 8, 2012, Pages 1507-1521

  Yao, Jia ^a   Irwin, Ronald ^a   Chen, Shuhua ^a   Hamilton, Ryan ^a   Cadenas, Enrique ^a   Brinton, Roberta Diaz ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Alzheimer's; Bioenergetics; Estrogen; Mitochondria; Ovariectomy; Oxidative stress

Indexed keywords

AMYLOID BETA PROTEIN; BETA AMYLOID BINDING ALCOHOL DEHYDROGENASE; ESTRADIOL; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOENERGY; BRAIN METABOLISM; CELL ENERGY; CELL FUNCTION; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HORMONE DETERMINATION; MITOCHONDRIAL RESPIRATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

3-HYDROXYACYL COA DEHYDROGENASES; AGING; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; ESTRADIOL; FEMALE; MICE; MICE, KNOCKOUT; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84861895505     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.03.001     Document Type: Article

References (59)

1. 2010 Alzheimer's disease facts and figures. Alzheimers Dement 2010, 6:158-194. Alzheimer's Association.
2. Asthana S., Brinton R.D., Henderson V.W., McEwen B.S., Morrison J.H., Schmidt P.J. Frontiers proposal. National Institute on Aging "bench to bedside: estrogen as a case study". Age (Dordr) 2009, 31:199-210.
3. Beal M.F. Mitochondria take center stage in aging and neurodegeneration. Ann. Neurol 2005, 58:495-505.
4. Bélanger M., Magistretti P.J. The role of astroglia in neuroprotection. Dialogues Clin. Neurosci 2009, 11:281-295.
5. Berent-Spillson A., Persad C.C., Love T., Tkaczyk A., Wang H., Reame N.K., Frey K.A., Zubieta J.K., Smith Y.R. Early menopausal hormone use influences brain regions used for visual working memory. Menopause 2010, 17:692-699.
6. Blass J.P., Sheu R.K., Gibson G.E. Inherent abnormalities in energy metabolism in Alzheimer disease. Interaction with cerebrovascular compromise. Ann. N.Y. Acad. Sci 2000, 903:204-221.
7. Brinton R.D. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci 2008, 31:529-537.
8. Brinton R.D. Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends Pharmacol. Sci 2009, 30:212-222.
9. Cadenas E., Davies K.J. Mitochondrial free radical generation, oxidative stress, and aging. Free Radic. Biol. Med 2000, 29:222-230.
10. Carroll J.C., Pike C.J. Selective estrogen receptor modulators differentially regulate Alzheimer-like changes in female 3xTg-AD mice. Endocrinology 2008, 149:2607-2611.
11. Carroll J.C., Rosario E.R., Chang L., Stanczyk F.Z., Oddo S., LaFerla F.M., Pike C.J. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci 2007, 27:13357-13365.
12. Chan D.C. Mitochondria: dynamic organelles in disease, aging, and development. Cell 2006, 125:1241-1252.
13. Cho D.H., Nakamura T., Fang J., Cieplak P., Godzik A., Gu Z., Lipton S.A. S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 2009, 324:102-105.
14. Edland S.D., Silverman J.M., Peskind E.R., Tsuang D., Wijsman E., Morris J.C. Increased risk of dementia in mothers of Alzheimer's disease cases: evidence for maternal inheritance. Neurology 1996, 47:254-256.
15. Gandy S., Caporaso G., Buxbaum J., Frangione B., Greengard P. APP processing, A beta-amyloidogenesis, and the pathogenesis of Alzheimer's disease. Neurobiol. Aging 1994, 15:253-256.
16. Grieb P., Gordon-Krajcer W., Frontczak-Baniewicz M., Walski M., Ryba M.S., Kryczka T., Fiedorowicz M., Kulinowski P., Sulek Z., Majcher K., Jasinski A. 2-deoxyglucose induces beta-APP overexpression, tau hyperphosphorylation and expansion of the trans-part of the Golgi complex in rat cerebral cortex. Acta Neurobiol. Exp 2004, 64:491-502.
17. Henderson V.W. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy: progress in brain research. Neuroendocrinology 2010, 182:77-96.
18. Hirai K., Aliev G., Nunomura A., Fujioka H., Russell R.L., Atwood C.S., Johnson A.B., Kress Y., Vinters H.V., Tabaton M., Shimohama S., Cash A.D., Siedlak S.L., Harris P.L., Jones P.K., Petersen R.B., Perry G., Smith M.A. Mitochondrial abnormalities in Alzheimer's disease. J. Neurosci 2001, 21:3017-3023.
19. Irwin R.W., Yao J., Hamilton R.T., Cadenas E., Brinton R.D., Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endocrinology 2008, 149:3167-3175.
20. Lopez-Grueso R., Borras C., Gambini J., Viña J. Aging and ovariectomy cause a decrease in brain glucose consumption in vivo in Wistar rats [in Spanish]. Rev. Esp. Geriatr. Gerontol 2010, 45:136-140.
21. Lustbader J.W., Cirilli M., Lin C., Xu H.W., Takuma K., Wang N., Caspersen C., Chen X., Pollak S., Chaney M., Trinchese F., Liu S., Gunn-Moore F., Lue L.F., Walker D.G., Kuppusamy P., Zewier Z.L., Arancio O., Stern D., Yan S.S., Wu H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004, 304:448-452.
22. Magistretti P.J. Neuron-glia metabolic coupling and plasticity. J. Exp. Biol 2006, 209:2304-2311.
23. Maki P.M., Dennerstein L., Clark M., Guthrie J., Lamontagne P., Fornelli D., Little D., Henderson V.W., Resnick S.M. Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res 2011, 1379:232-243.
24. Maki P.M., Resnick S.M. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol. Aging 2000, 21:373-383.
25. Maki P.M., Resnick S.M. Effects of estrogen on patterns of brain activity at rest and during cognitive activity: a review of neuroimaging studies. Neuroimage 2001, 14:789-801.
26. Martins R.N., Hallmayer J. Age at onset: important marker of genetic heterogeneity in Alzheimer's disease. Pharmacogenomics J 2004, 4:138-140.
27. Moreira P.I., Santos M.S., Seiça R., Oliveira C.R. Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes. J. Neurol. Sci 2007, 257:206-214.
28. Moreira P.I., Zhu X., Wang X., Lee H.G., Nunomura A., Petersen R.B., Perry G., Smith M.A. Mitochondria: a therapeutic target in neurodegeneration. Biochim. Biophys. Acta 2010, 1802:212-220.
29. Mosconi L., Mistur R., Switalski R., Brys M., Glodzik L., Rich K., Pirraglia E., Tsui W., De Santi S., de Leon M.J. Declining brain glucose metabolism in normal individuals with a maternal history of Alzheimer disease. Neurology 2009, 72:513-520.
30. Mosconi L., Rinne J.O., Tsui W.H., Berti V., Li Y., Wang H., Murray J., Scheinin N., Nagren K., Williams S., Glodzik L., De Santi S., Vallabhajosula S., de Leon M.J. Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:5949-5954.
31. Mosconi L., Sorbi S., de Leon M.J., Li Y., Nacmias B., Myoung P.S., Tsui W., Ginestroni A., Bessi V., Fayyazz M., Caffarra P., Pupi A. Hypometabolism exceeds atrophy in presymptomatic early-onset familial Alzheimer's disease. J. Nucl. Med 2006, 47:1778-1786.
32. Nicholson R.M., Kusne Y., Nowak L.A., Laferla F.M., Reiman E.M., Valla J. Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models. Brain Res 2010, 1347:179-185.
33. Nilsen J., Irwin R.W., Gallaher T.K., Brinton R.D. Estradiol in vivo regulation of brain mitochondrial proteome. J. Neurosci 2007, 27:14069-14077.
34. Nunomura A., Hofer T., Moreira P.I., Castellani R.J., Smith M.A., Perry G. RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol 2009, 118:151-166.
35. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
36. Petanceska S.S., Nagy V., Frail D., Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology 2000, 54:2212-2217.
37. Rasgon N.L., Silverman D., Siddarth P., Miller K., Ercoli L.M., Elman S., Lavretsky H., Huang S.C., Phelps M.E., Small G.W. Estrogen use and brain metabolic change in postmenopausal women. Neurobiol. Aging 2005, 26:229-235.
38. Reddy P.H., Beal M.F. Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med 2008, 14:45-53.
39. Reiman E.M. Linking brain imaging and genomics in the study of Alzheimer's disease and aging. Ann. N. Y. Acad. Sci 2007, 1097:94-113.
40. Reiman E.M., Chen K., Alexander G.E., Caselli R.J., Bandy D., Osborne D., Saunders A.M., Hardy J. Correlations between apolipoprotein E epsilon4 gene dose and brain-imaging measurements of regional hypometabolism. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:8299-8302.
41. Rocca W.A., Bower J.H., Maraganore D.M., Ahlskog J.E., Grossardt B.R., de Andrade M., Melton-Iii L.J. Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology 2007, 69:1074-1083.
42. Rocca W.A., Grossardt B.R., Shuster L.T. Oophorectomy, Menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener. Dis 2010, 7:163-166.
43. Shumaker S.A., Legault C., Rapp S.R., Thal L., Wallace R.B., Ockene J.K., Hendrix S.L., Jones B.N., Assaf A.R., Jackson R.D., Kotchen J.M., Wassertheil-Smoller S., Wactawski-Wende J. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003, 289:2651-2662. WHIMS Investigators.
44. Simpkins J.W., Dykens J.A. Mitochondrial mechanisms of estrogen neuroprotection. Brain Res. Rev 2008, 57:421-430.
45. Simpkins J.W., Yi K.D., Yang S.H., Dykens J.A. Mitochondrial mechanisms of estrogen neuroprotection. Biochim. Biophys. Acta 2009, 1800:1113-1120.
46. Swerdlow R.H., Khan S.M. The Alzheimer's disease mitochondrial cascade hypothesis: an update. Exp. Neurol 2009, 218:308-315.
47. Takuma K., Yao J., Huang J., Xu H., Chen X., Luddy J., Trillat A.C., Stern D.M., Arancio O., Yan S.S. ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction. FASEB J 2005, 19:597-598.
48. Velliquette R.A., O'Connor T., Vassar R. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis. J. Neurosci 2005, 25:10874-10883.
49. Viña J., Borrás C., Gambini J., Sastre J., Pallardó F.V. Why females live longer than males?. Importance of the upregulation of longevity-associated genes by oestrogenic compounds. FEBS Lett 2005, 579:2541-2545.
50. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet 2005, 39:359-407.
51. Wang X., Su B., Lee H.G., Li X., Perry G., Smith M.A., Zhu X. Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J. Neurosci 2009, 29:9090-9103.
52. Whitmer R.A., Quesenberry C.P., Zhou J., Yaffe K. Timing of hormone therapy and dementia: The critical window theory revisited. Ann. Neurol 2011, 69:163-169.
53. Will Y., Hynes J., Ogurtsov V.I., Papkovsky D.B. Analysis of mitochondrial function using phosphorescent oxygen-sensitive probes. Nat. Protoc 2006, 1:2563-2572.
54. Yaffe K., Barnes D., Lindquist K., Cauley J., Simonsick E.M., Penninx B., Satterfield S., Harris T., Cummings S.R. Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort. Neurobiol. Aging 2007, 28:171-178.
55. Yang J.L., Weissman L., Bohr V.A., Mattson M.P. Mitochondrial DNA damage and repair in neurodegenerative disorders. DNA Repair (Amst) 2008, 7:1110-1120.
56. Yao J., Hamilton R.T., Cadenas E., Brinton R.D. Decline in mitochondrial bioenergetics and shift to ketogenic profile in brain during reproductive senescence. Biochim. Biophys. Acta 2010, 1800:1121-1126.
57. Yao J., Irwin R.W., Zhao L., Nilsen J., Hamilton R.T., Brinton R.D. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:14670-14675.
58. Zandi P.P., Carlson M.C., Plassman B.L., Welsh-Bohmer K.A., Mayer L.S., Steffens D.C., Breitner J.C. Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. JAMA 2002, 288:2123-2129. Cache County Memory Study Investigators.
59. Zhao d.L., Yao J., Mao Z., Chen S., Wang Y., Brinton R.D. Estradiol regulates insulin-degrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: Relevance to Alzheimer's prevention. Neurobiol. Aging 2010, 2010 Jan 4. [Epub ahead of print]. 10.1016/j.neurobiolaging.2009.12.010.